Table 1.
Characteristic | Pretrial population (N = 2335) |
---|---|
Age, y | 72.9 (68.0-79.3) |
Age ≥80 y, n (%) | 535 (22.9) |
Female, n (%) | 1418 (60.7) |
TSH, mIU/L | |
First measurement (screening) | 5.40 (4.91-6.31) |
>7 mIU/L, n (%) | 368 (15.8) |
>10 mIU/L, n (%) | 57 (2.4) |
Second measurement (trial baseline) | 4.02 (3.01-5.42) |
fT4, pmol/L | |
First measurement (screening)a | 13.6 (12.3-15.0) |
Second measurement (trial baseline) | 13.0 (12.0-14.6) |
Interval between first and second measurements | 344 (207-594) |
<6 mo, n (%) | 465 (19.9) |
6-12 mo, n (%) | 778 (33.3) |
>12 mo, n (%) | 1092 (46.8) |
Season of second measurement (trial baseline), n (%) | |
Summer | 764 (32.7) |
Autumn | 735 (31.5) |
Winter | 318 (13.6) |
Spring | 518 (22.2) |
Country, n (%) | |
United Kingdom | 494 (21.2) |
Ireland | 667 (28.6) |
The Netherlands | 1174 (50.3) |
Values shown are median (interquartile range) unless indicated otherwise.
Abbreviation: fT4, free T4.
a First fT4 measurement was missing for n = 10.